Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

SKINVIVE™ by JUVÉDERM® is Now FDA Approved, with Dr. Ran Rubinstein, MD selected as a Clinical Trainer


News provided by

Laser & Cosmetic Surgery Specialists

May 23, 2023, 00:00 ET

Share this article

Share toX

Share this article

Share toX

SKINVIVE by JUVEDERM
SKINVIVE by JUVEDERM

Dr. Ran Y. Rubinstein of Laser & Cosmetic Surgery Specialists announces FDA approval of SKINVIVE™ by JUVÉDERM®, the first HA intradermal microdroplet injection for skin by Allergan Aesthetics.

NEWBURGH, N.Y., May 23, 2023 /PRNewswire-PRWeb/ -- Laser & Cosmetic Surgery Specialists, the renowned cosmetic clinic headed by Dr. Ran Y. Rubinstein, is thrilled to announce the introduction of SKINVIVE™ by JUVÉDERM®, a groundbreaking development in aesthetic medicine. As of this month, SKINVIVE™ is now FDA approved and has been named the first and only hyaluronic acid (HA) intradermal microdroplet injection for skin, developed by Allergan Aesthetics, an AbbVie company.

SKINVIVE™ by JUVÉDERM® is a revolutionary hyaluronic acid-based skin enhancement product formulated to improve skin hydration, elasticity, and smoothness. It has been approved by the FDA after rigorous testing and proven efficacy in replenishing and maintaining skin health. The product represents a significant breakthrough in aesthetic medicine, and Dr. Rubinstein is proud to have been selected as a clinical trainer for Allergan Aesthetics in this innovative procedure.

Hyaluronic acid has long been recognized for its restorative properties and is a primary component of many successful dermal fillers. Now, we have an innovative way to deliver these benefits more effectively, improving skin quality with a quick, minimally invasive procedure.

Post this

Dr. Rubinstein, an esteemed plastic surgeon with over 20 years of experience, will be at the forefront of bringing this state-of-the-art treatment to patients. He is recognized for his expertise and commitment to patient care and continues to contribute significantly to the field of aesthetic medicine.

"We are excited to provide this innovative solution to our patients," said Dr. Rubinstein. "The FDA approval of SKINVIVE™ by JUVÉDERM® stands as a testament to its effectiveness and safety. As a clinical trainer for Allergan Aesthetics, I am looking forward to teaching other physicians about the benefits of this treatment and helping them implement it in their practice."

Laser & Cosmetic Surgery Specialists, located in the heart of Newburgh, NY, has been serving clients with top-quality services and treatments for decades. The clinic prides itself on a personalized approach to aesthetic medicine, ensuring that each patient receives individualized care tailored to their unique needs. With the introduction of SKINVIVE™, the clinic is furthering its mission to provide the latest and most effective treatments to its patients.

Dr. Rubinstein's role as a clinical trainer for Allergan Aesthetics reaffirms his status as a leader in the field. His clinic, Laser & Cosmetic Surgery Specialists, will serve as a hub for teaching and learning about the application of SKINVIVE™.

"FDA approval of SKINVIVE™ is a leap forward in the field of cosmetic medicine," Dr. Rubinstein added. "Hyaluronic acid has long been recognized for its restorative properties and is a primary component of many successful dermal fillers. Now, we have an innovative way to deliver these benefits more effectively, improving skin quality with a quick, minimally invasive procedure."

About Dr. Ran Y. Rubinstein, MD

Dr. Ran Y. Rubinstein is a highly respected plastic surgeon known for his exceptional skills, innovative techniques, and commitment to patient care. With over two decades of experience in the field, he has built a reputation for delivering natural-looking results that enhance each patient's unique beauty. He specializes in facial plastic surgery. Dr. Rubinstein is board certified by the American Board of Facial Plastic Surgery and the American Board of Otolaryngology-Head and Neck Surgery.

Dr. Rubinstein's dedication to his patients extends beyond the surgical suite. He is an educator at heart, consistently sharing his expertise and insights with patients and fellow professionals alike. His role as a clinical trainer for Allergan Aesthetics, teaching the application of the newly approved SKINVIVE™ by JUVÉDERM®, is an extension of this commitment to knowledge sharing and ongoing professional development in the field of aesthetic medicine.

At Laser & Cosmetic Surgery Specialists, PC, Dr. Rubinstein's philosophy is deeply rooted in creating customized treatment plans for patients, ensuring that each individual's aesthetic goals are met with the utmost precision and care. His mastery of various aesthetic procedures, combined with his warm and compassionate approach, continues to set him apart in the field. His leadership and the addition of SKINVIVE™ by JUVÉDERM® to his practice further solidify his position as a pioneer in cosmetic surgery.

About Laser Cosmetic Surgery Specialists

Laser & Cosmetic Surgery Specialists, PC is a leading plastic surgery clinic situated in Newburgh, New York. It has garnered a reputation for excellence under the leadership of Dr. Ran Y. Rubinstein. The state-of-the-art facility specializes in cosmetic surgery of the face, body, and skin while also offering a range of non-surgical solutions, now including SKINVIVE™ by JUVÉDERM®.

The clinic is committed to delivering the highest standards of patient care and safety. Each patient receives a customized treatment plan designed to address their unique needs and aesthetic goals. The clinic's dedicated team ensures a comfortable and supportive environment, guiding patients through their journey toward enhanced self-confidence and well-being.

At Laser & Cosmetic Surgery Specialists, continuous innovation and education are paramount. The team stays abreast of the latest trends and technological advancements in the field of cosmetic surgery, ensuring that their patients have access to the most effective treatments. The inclusion of SKINVIVE™ by JUVÉDERM® highlights their commitment to leading-edge treatments and excellence in patient care.

Contact the Clinic

Patients interested in experiencing the cutting-edge SKINVIVE™ by JUVÉDERM® treatment are encouraged to reach out to Laser & Cosmetic Surgery Specialists to schedule a consultation. Dr. Rubinstein and his expert team are eager to assist patients in exploring the benefits of this transformative procedure.

In the pursuit of aesthetic excellence and patient satisfaction, Laser & Cosmetic Surgery Specialists continually strive to incorporate the latest advancements into their practice. With SKINVIVE™ by JUVÉDERM® now part of their service offerings, they look forward to serving their patients with an even higher standard of care.

For more information or to book a consultation, please visit http://www.yourfacemd.com or call the clinic directly at 845-863-1772.

Media Contact

Ran Y. Rubinstein, MD, Laser & Cosmetic Surgery Specialists, (845) 863-1772, [email protected]

SOURCE Laser & Cosmetic Surgery Specialists

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.